Table 3.
Base model | Model 1: Base + postmenopause |
Model 2: Base + hormones |
Model 3: Base + hormones + HOMA |
|
---|---|---|---|---|
Parameter | Estimate (s.e.)a | Estimate (s.e.)a | Estimate (s.e.)a | Estimate (s.e.)a |
% Body Fat | 0.608 (0.038)*** | 0.607 (0.038)*** | 0.570 (0.036)*** | 0.523 (0.036)*** |
Age | 0.067 (0.037) | 0.024 (0.042) | 0.048 (0.036) | 0.047 (0.036) |
White race | 0.301 (0.072)*** | 0.306 (0.072)*** | 0.279 (0.067)*** | 0.322 (0.068)*** |
Framingham risk score | 0.233 (0.039)*** | 0.231 (0.039)*** | 0.214 (0.036)*** | 0.202 (0.036)*** |
Depression (dichotomous) | 0.194 (0.106) | 0.200 (0.106) | 0.260 (0.098)* | 0.180 (0.098)* |
Physical activity | −0.073 (0.037)* | −0.075 (0.037)* | −0.074 (0.034)* | −0.055 (0.034) |
Postmenopause indicator | 0.174 (0.084)* | |||
Insulin resistance (HOMA-IR)b | 0.207 (0.035)*** | |||
Bioavailable testosteroneb | 0.202 (0.033)*** | 0.166 (0.034)*** | ||
Estradiolb | −0.007 (0.034) | 0.024 (0.034) | ||
R2 | 0.574 | 0.579 | 0.614 | 0.649 |
HOMA-IR, homeostasis model assessment for insulin resistance.
Estimates are standardized β-coefficients and standard errors.
Transformed by logarithm to base 10.
P ≤ 0.05,
P ≤ 0.01,
P ≤ 0.001.